CHG-2022-0199

New Dosage Strength for Brextanib. Labeling Change for Brextanib — critical change. Impacts 1 markets and 1 variations.

Change Number
CHG-2022-0199
Type
New Dosage Strength
Product
Brextanib
Status
Pending
Owner
Lieselotte van der Berg
Initiated
2023-04-02
Description

Labeling Change for Brextanib — critical change

Impacted Markets (1)
TR — Turkey
Impacted Modules
3.2.P2.3.P3.2.S4.2.1
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved